| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $11,461,524 ) (Continued on the next page) |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R35GM130326 | Dynamics of DNA scanning and recognition by proteins | 001 | 8 | NIH | 3/23/2026 | $53,600 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R35GM130326 | Dynamics of DNA scanning and recognition by proteins | 000 | 8 | NIH | 1/27/2026 | $482,400 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AG083102 | Annual wellness visit policy: Impact on disparities in early dementia diagnosis and quality of healthcare for Medicare beneficiaries with Alzheimer's Disease and Its Related Dementias | 001 | 4 | NIH | 6/25/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AG083102 | Annual wellness visit policy: Impact on disparities in early dementia diagnosis and quality of healthcare for Medicare beneficiaries with Alzheimer's Disease and Its Related Dementias | 000 | 4 | NIH | 4/7/2026 | $544,644 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01DA038446 | 5-HT2 Receptor Allosterism in Cocaine Use Disorder | 000 | 10 | NIH | 4/29/2026 | $538,887 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | DP2AI154410 | Revealing the Biophysics of the Germinal Center Microenvironment | 000 | 5 | NIH | 12/3/2025 | $480,000 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | T32DA007287 | Translational Explorations in Substance Use Disorders | 000 | 29 | NIH | 5/13/2026 | $194,103 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | T32GM008256 | Postdoctoral Training in Trauma and Burns | 000 | 34 | NIH | 6/3/2026 | $201,352 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01DK077148 | Metabolic and xenobiotic control of thyroid hormone metabolism | 000 | 13 | NIH | 2/24/2026 | $423,748 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01MH077303 | Synaptic Organizers: Dynamic Regulation of Trans-synaptic Bridges | 000 | 19 | NIH | 12/16/2025 | $737,907 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01EY037126 | The Role of mtDNA/ZBP1 in Retinal Neurodegeneration | 002 | 2 | NIH | 2/19/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AI176670 | Porous silicon microparticle-based subunit vaccines for SARS-CoV-2 | 000 | 4 | NIH | 2/6/2026 | $751,347 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AG077253 | The Role of Ubiquitination in Tau Oligomers Pathogenesis | 001 | 5 | NIH | 6/26/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AG077253 | The Role of Ubiquitination in Tau Oligomers Pathogenesis | 000 | 5 | NIH | 3/23/2026 | $748,330 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01DK133364 | Role of proteolytic suPAR fragment in insulin dependent diabetes and kidney disease | 000 | 5 | NIH | 5/11/2026 | $659,230 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R35GM159909 | Deciphering Mechanosignaling Using Multi-fluorescence Biomembrane Force Probe | 000 | 2 | NIH | 5/19/2026 | $440,000 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01DA060228 | Discovery of GPR52 ligand probes for cocaine use disorder | 000 | 2 | NIH | 5/26/2026 | $795,090 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01MH132226 | Probing brain circuit and behavior with protein:protein interaction modulators | 000 | 4 | NIH | 12/10/2025 | $794,232 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | U2RTW012239 | 2/2 - Mongolian Center for Environmental & Occupational Health - U.S. | 000 | 5 | NIH | 6/1/2026 | $74,331 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | U2RTW012239 | 2/2 - Mongolian Center for Environmental & Occupational Health - U.S. | 000 | 5 | NIH | 6/1/2026 | $100,000 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | U2RTW012239 | 2/2 - Mongolian Center for Environmental & Occupational Health - U.S. | 001 | 5 | NIH | 6/11/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | U2RTW012239 | 2/2 - Mongolian Center for Environmental & Occupational Health - U.S. | 001 | 5 | NIH | 6/11/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | U2RTW012239 | 2/2 - Mongolian Center for Environmental & Occupational Health - U.S. | 001 | 5 | NIH | 6/11/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | U2RTW012239 | 2/2 - Mongolian Center for Environmental & Occupational Health - U.S. | 000 | 5 | NIH | 6/1/2026 | $118,383 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01NS140424 | Sculpting Membrane Dynamics: Membrane-Remodeling Factors Shape Oligodendroglial Form and Function | 001 | 2 | NIH | 3/18/2026 | $45,818 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01NS140424 | Sculpting Membrane Dynamics: Membrane-Remodeling Factors Shape Oligodendroglial Form and Function | 000 | 2 | NIH | 1/26/2026 | $412,371 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AG089205 | Demography of Immigrant Mortality in the United States: Leveraging Novel Census Linkages to Death Records, Earnings Trajectories, and Residential Mobility | 000 | 3 | NIH | 5/26/2026 | $643,033 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R61AI179997 | Generation of Orientia tsutsugamushi mutant strains for pathogenesis research | 000 | 3 | NIH | 1/13/2026 | $275,062 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | U01AI168622 | One-Health Approach to Study Human Fasciola hepatica Transmission and Inform Strategic Control | 000 | 5 | NIH | 6/24/2026 | $239,271 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AG088215 | The function of post-translational modifications of myosin and its chaperone UNC-45 that occur with adult aging | 000 | 3 | NIH | 5/26/2026 | $561,893 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AI158422 | Ehrlichia Notch SLiM-activated oncoprotein inhibition of apoptosis | 000 | 5 | NIH | 12/2/2025 | $400,000 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01MH134761 | Targeting cell-to-cell communication to prevent bystander damage mediated by viral reservoirs | 000 | 3 | NIH | 1/27/2026 | $689,960 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01NS131507 | The role of neuro-immune interactions in PACAP induced migraine | 000 | 3 | NIH | 2/20/2026 | $499,611 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R35GM151324 | Dissecting the Mechanisms of Quaking-Regulated RNA Processing | 000 | 4 | NIH | 5/19/2026 | $400,000 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R03NS144710 | Development of a Mouse Model to Investigate the Role of ZBP1 in Neuroinflammation | 001 | 1 | NIH | 6/11/2026 | $1,500 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R03NS144710 | Development of a Mouse Model to Investigate the Role of ZBP1 in Neuroinflammation | 000 | 1 | NIH | 6/9/2026 | $160,000 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01GM149683 | Impact of ATR's role in translesion synthesis on prevention of DNA damage induced mutagenesis and chromosomal instability | 001 | 4 | NIH | 3/10/2026 | $32,000 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01GM149683 | Impact of ATR's role in translesion synthesis on prevention of DNA damage induced mutagenesis and chromosomal instability | 000 | 4 | NIH | 1/29/2026 | $288,000 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01DK132072 | Targeting bone marrow to treat renal disease | 000 | 4 | NIH | 1/8/2026 | $468,449 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R35GM150459 | Dynamic regulatory impact of human transposable elements on gene expression | 000 | 4 | NIH | 5/27/2026 | $387,465 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01EY034616 | Anti-Aging Molecule Sirt6 in Neuroprotection in Diabetic Retina | 000 | 4 | NIH | 4/28/2026 | $541,883 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AI184781 | Pre-clinical studies to repurpose FDA-approved adenosine A2A receptor antagonists for lethal rickettsial infection | 000 | 2 | NIH | 6/26/2026 | $463,698 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01DA060221 | Frustration effects on drug taking | 000 | 3 | NIH | 4/8/2026 | $400,000 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01ES033682 | Hepatic Aryl Hydrocarbon Receptor Regulation of Obesity: Mechanisms of Action | 000 | 5 | NIH | 6/16/2026 | $356,219 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R35GM148364 | Mechanisms for the high fidelity of translesion synthesis by Y-family DNA polymerases in human cells | 001 | 4 | NIH | 3/20/2026 | $43,180 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R35GM148364 | Mechanisms for the high fidelity of translesion synthesis by Y-family DNA polymerases in human cells | 000 | 4 | NIH | 12/9/2025 | $388,626 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | K01AG075254 | Sex Differences in Pain and Treatment and their Association with Alzheimer’s Disease and Related Dementias | 000 | 5 | NIH | 6/23/2026 | $123,750 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | U24FD007821 | An Educational Program to Enhance Data Quality and Integrity for Regulated Studies Supporting the Advancement of Medical Countermeasures for High Consequence Pathogens | 001 | 4 | FDA | 3/17/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | F30DA065327 | Mechanisms of prenatal opioid exposure on offspring brain development and behavior | 001 | 1 | NIH | 3/25/2026 | $576 |
|
